Title : Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment.

Pub. Date : 1997 Sep

PMID : 9313875






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The 112 patients receiving the melphalan autografts fared significantly better than the rest of the patients with OS and PFS (from high-dose treatment) of 6.6 years and 27 months, respectively (P < 0.005), and the 57 patients also receiving IFN have a OS yet to reach a median at 8 years and a PFS of 44 months, significantly better than non IFN high-dose patients (P < 0.0036). Melphalan interferon alpha 1 Homo sapiens
2 The 112 patients receiving the melphalan autografts fared significantly better than the rest of the patients with OS and PFS (from high-dose treatment) of 6.6 years and 27 months, respectively (P < 0.005), and the 57 patients also receiving IFN have a OS yet to reach a median at 8 years and a PFS of 44 months, significantly better than non IFN high-dose patients (P < 0.0036). Melphalan interferon alpha 1 Homo sapiens